The Northern Manhattan study (NOMAS) prospectively assessed 2,525 individuals from a racially diverse population and concluded that elevated FGF23 conferred an overall risk of stroke and intracerebral hemorrhage independent of CKD[8]. The gene discussed is FGF23; the disease is intracerebral hemorrhage.